{"ticker": {"uuid": "5aee0440-2bab-4e30-b16e-000aa7acbda4", "symbol": "ABL", "name": "Abbott Laboratories", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxORk9ENlh5SlJsMWUxNEQxVlpSRENmeGxhU0hUdE02bERwWWZRSEZTeWRKZ1BuREhJOUppdTVnV0VjZ0tibGRpa0lzR1h4OXJNM1ZQdjA1YXVJbkZnd3N6U2xGX3hjaFVESWp5RWpQN2tOVG96ZnpCMUhZd0hha3NMZ3Z0Z1pEbHNpM2ZVSEFQQUVIQjFVTGNUUmlFNXhBQ3pmWWl3ODV5V29FeVdIVmNUMnJfN2xKTm9hQ3RGSTFqeEhIVGtrU3c?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T17:35:02+00:00", "published_display": "17 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Stock Draws Fresh Targets As Growth Story Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1SQXlNY2ZFUTA4bmlFdnY3dzF6ZHFmUzY3RkhwWERmVFVseTZoWEpyazZ4V1VoQ1ctdmp4QUFRZHN4bk5NM2tRRHB6OGhoYVRHVHpIRExkRWJKcnNabFRSZjhRUkwzaEZZZ2tFSVBWN2JIY0dienJyT3V5LWNQdw?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-16T20:03:00+00:00", "published_display": "16 Jul 2026 20:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Q2 Profit Plunges, Lifts FY26 Adj. EPS View, Backs Sales Forecast; Stock Up 11%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQODRsZHJHSEhSU0lMQ1RxdU5adUt5YnRKS1JDb2d3UTBwQTFvbElDVHNtd2JHbjFzNVRkb19NNmtCX2ViSFBWOU9JWlQ0Y3I1cEM4ZW1NdDZoUGI4ZDcwY1JPc1hBRC1yRzdzak1yUDVBanZaMTJmUklFY2Z4VjRCZHBRS0dUbEhvNEgyejZTbHQ5SzhSQ1lJdUxnUFBwZVppT0NUZHl1Ykx3WGJ5bWVGMG9pLTMyczUzQVE?oc=5", "source_name": "RTTNews", "published_at": "2026-07-16T13:41:00+00:00", "published_display": "16 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector\u2019s 9% Earnings Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnFlY0xtUFY4QVFXSFEzQVRZTVRtaVdRaXFUTlJuRk5TX1BhWTlVVU9sU3psYzQwU2haeTN5OFlNTlFzeHZmN05SRlZHNUVfTzc5VjJuRERSMURsU21Qb1NPai1kWU9TVElIb3B0WGZBQnBSSGdVbDR3YWhVcGZnUUs1NC1KMEpKWG5WU3c2bzlvQ19uLTF0ZjF4cGw2cG8?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-07-12T21:01:30+00:00", "published_display": "12 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPcndKYnEwLTdDRXVCaUp2V0poRDlTdDRwd2JDdDlaWVY2T2FkVUxDamRlTzZQemdUaGVkTzc2Mk1ULVktTmVFRG9jd21iaWhFNFpaS3JqNVQwYUNuUUxtY1lmbmxSVmh2M2Q2Y3NPMk1RcFk1OTJNeldreTJ5NUxhc1FGSmF2NVpsTndjS0psdjR6d1VLWEJOeF9JRjE?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories (ABT) director granted 416 stock equivalent units as board fees", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPNi1pV2VVcGZkcVdqdDJJcGhOTUFUYm0zZVE2Z0piRDVlR1hMd1BNUnR3TVpoQlp1cm8tbUxlT2l5ckh1Y1E1UmRfeGRRYkdHWmluRmNPVksyZVV1WUN4VWQwMUkxa2FfMHJLN0ZBdmRQOGNHYWJDQjcwTU5PN3ZubXBuNU5DdE05eV9UeTBiYmlPMlkzQlZtV1hDZXlPSUZIZWRtdDhLM05yV2h1UVFFa21n?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott to post Q2 results July 16, then host live webcast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOQjFSSW9MR016TEhCLVlWZVVQVzFXYnhhN1NPTUJyc0FHWHdTVTV1UGZnTG10NHJ2d1JRNENMMzJZQ3A3OElsaUN5YUxMVXBPVzlCVnhVNEhYZy1HYjhWVDVXcVdDbVZTdU1acFdtNHVlY0dybVYtX0R3dUQ1Yk5fZHBfb3pQTUlqZmpIdVNJUzdrdks3OEhrT0tKa2k1YjV6Q2ZZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories confirms CE mark for dual sensor, shares in S&P 500 healthcare focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONDYxcWR1WG43R2dUVFN0NTRPRVJhSVZuXzFJdjBZMlBZa1A5UFFFak04N09uUTFsYUJvUzRNYWVpVVdGX0ROcVM2Zk1XQTdzZzdaMUo0X19NUHd6emtfak82NTlKbTA1OUtuZWNYTVEwc25FT25VR0RSWEVpRG5Tb0VaekFxWWEwQS1PSmRRcDRoaGhjVzNCdWZWU1FWM19ieW5Vc3BRcU1tUnh5VUlLMkEzWjNXRkprRHVIVXptR1BwcjRUa0k4Ug?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late to Buy Abbott Laboratories (ABT) After 4.4% Rally? GF Value Says Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxQdUhoWU9jRktHbE9QWXliMWh2N2h0U2k1aTRobU5OalZZdmZQYVZ6RlZUZ182Q09XeGtIc1hCaGduTzJfX19Va0RaR2NJM1d1TFhLMzc4N3lONXVYT3pkeEFMOXk2dHJZUVBMbGExM016YlNEYWdobEE4dWYzc3JnMUUya0h5aGZrOFRUbnBEbWZOcXRxSWU5a0JEWXhHcFhQNWFQREdDLVhyTE54TGlmQXR5cmliYlVQTzBHWWNWTU5NOFlnNklkdE5FWWw3X0EySTlXMkEyb3JMRUZLenlxV2drVnpCZUhK?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock (US0028241000): U.S. healthcare name steadies after recent slide as instit", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNM2J6VW9hcnU4OWloX1pIeGNTT0N5NGRTWUI4RkdCeFF2aWpmSExQRkhkbEladkFVbk9va0V5YXFnTW5lWXJUTkR0T1hLbFJFS2xwdHVjUzItOFpjODZXYkFfWFdSdk9ma3Mydmc1RzJnWm40Q2dHdlY2eWRkVHNwdzB4NGZFWXl3T0ExV0FpV3UyWGdnS0pLekVrVkxKZFdRaDZ0T1Z3Q2JnbHFmNzBiQjhCaDhEREtMdHdqQ0N3Ul81MjZK?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock (US0028241000): U.S. healthcare name steadies after recent ETF inclusion a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQZWhUU0N2UFRxbG5kMlF3ZXBoMjhoczVwUmFzUXFGeldxNy15TXpaN2daTFRzNWdHR2pJUmJaYklMUlFZZTR5WlZJcklzT0ZycUtDb0g1c0MyS014NUtLY25JN180d2g4SHplY0dvUW9ZcUpscEVMYU0yNzZCZHFtRllMOS15Q2lEZXE1N1plcEFzZUc4RGtYS2JqYlFsclE0R2o1djlrSHZNc0VZTlE1c2gzRmdKcEVtMWs3LVZwb2xVMWkt?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdmo4V3NlWG1xTVBPZk1MWnBVOXRSempmSzVCSU5fV2FKTjJSYURsXzV3QjREZmJNSXNxc3NlbDl5d0V3eE5iWXRrWkh5YWI4UFZuQWs1Y3BCS09oNjZRZ0hlX29CT3FweGJPLWFkTndKUF85N05aaEYxVm5IclJGQTlTVVBzaG80Q0lWLVJEUkhuVElkQlE?oc=5", "source_name": "IndexBox", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABT: Abbott Laboratories Director Acquires 10,000 Shares Amid De", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOX0hYNm1YZHVEbklrQmt0RXV2akYzVkxXd3FhQU8wNkt4Z1V6V0ZvOGh1Vnl4UVBuRy1ITW1oWEtxWG5NUGhkM0xDQ0JPbloxblBPYXA3TlhwbklUdDdoX2RXUzFfQVl3VXdWXzBqQWI1RnNXNjl0YzREWUpqdXhIYnVsdG5xSTlYUkFsUGx0TGlaMks0azNCNVhINmNjM0RMSFp1M2J6bmVqZlpEMlYyUlpPRE1aRDY5LXhtTA?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon\u2122 3.0 Software", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNM3g4Mi1ySE9SOTk1bEJFYUd3cndHUkhIRllVMXVQb2czaFJuVVl0TDNoM0xMV0NfaFhMMDJaWUVMaF9aSHRyYUoxZHV3QUpXUWxuX3c3aGM1R1JfZ2xKNXZZdmtzejdlcmN3d0N1TkNFTlJRck5zQmpnX1ZkcmlUQ0JQRmdTREtBRk1mRjFveUdlRFV6SnhNcXNrVk9LcGM1V2hXLWMzV2I?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (NYSE: ABT) CFO adds 2,200 shares in open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOSUh2YlRhel83ZlF1cHdKZFhCMU1weHN4czY0TVdha2k3bnV4WXRyV190cEFYV3BocWJVTWJoOEJjWGpSRE54OFNxb0ptaW4xMjk4VzR0RW5kM0xjWlRaZ0VEbFVKVlRCSGhyXzBBLWxFaTlOX0RWa3hHWVFUV1pqLWx4YTN2NHVsanNJZGltMkVfS3JZek1oSkRqTHd3NDlZUC12dURodnNQSzd4Q1ZjYlFB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (ABT) director Gonzalez receives 321 stock equivalent units as fees", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNX3lWTF81YXV2Z0F2dFlvaU0wZ2gwUjVyWURBVG5kLVZKODFnZDNES3FQYkRvdzBYTTFObmNtZ2VWY29BYUZPaWFZal9QcFA2d3doU1p4ejdkY2RHT0s0S0swUm9fVVpxNkRLMHNPd1M1XzV1OGtSYnI2SkJlY2NEakJxM0V4VjdxNXBXM0c0QXBZRVBhU3BUN2h5YkV6eGlSemhXcnZ4cWltdE16Y2VhWlV3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQR3R4V19DdlJINXJqRy1WQjhKTm4tck5oT1FOc1pYbjNCQUdXY1RLQmtoa21JQzVmRU95eUJQZDJjZjJudURxQlEyd2FkT0Zhckc3M2FLVjd6OU1ZSy02cE1nT25wNzdTRF9uNE43SmFuRGtNWHJ4SEhQalVCTXRBek55UkVGTWtYQW02bXVuenRxY0NaY0g2bXdrbGdHZEZaMTJKazBRMFkzb3pp?oc=5", "source_name": "IndexBox", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intuitive Surgical Upgraded to Buy by Citi \u2014 Plus Key Moves on Stryker and Abbott", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNzUydURTRW1xNVVvR0JhTFl3NGZ5clhCY2IzWmtYZHd0R1d5WndyY3AwMGo5VGNucVdPbUt0U0tldW9Db1FiUGlqWkFwNU92T1dOVDhaV1VzTHNjalFVT1J2eWg5YmtKSHhxdk1SNDJwSkhGUU9LQUp5cXRFZ1d6Z0RBM2E4UjhJc2NoSkozNmQ1ZjZibFhYa0Zac0pkcFBPbzdGYlo4aHVTaU5OR0M2Sm00cmFaMmYyVzB6QW9uVEM?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After a 15% Drop, Is Abbott Stock Set Up for a Comeback in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNMDYzNGNjZlhLai1jcjJTcjBJOG5PNzNSdkhaLWRsd2dldFh6bHJUbUhiWGFteFhJSkVkNHBPUk16anJLVGROX0w3RGxrLUtHVERHd3JaWURBQ2xmSzFJWk80TWtkQnBPaElBSENubFlJQXN1cmlXVkI0UFowWm9Bb2Q3cFdkaHNBSDQ2MWtHLXk?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock (ABT) Drops on Lower Full-Year Outlook; Sales Meet Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxONXhiOEFhUHFiQVhxRTFabXZYX3Jmc1BuZDhZczRMQmxZOE1NVzI5b2xZcW9qdnJzX2xpOEhfTjloMk91X1ptNVpSQWk2VGh2ZzhjVHhYVExGYXRZWVV6VjZRUjVBZ0x4ckNJd3F5RUdXS0dRcGtBdlp6WUI4bXB6UWVYc0NOYXZsVWhaWlpINEFPWDcxRWptQ2Z1Sl9MYzlyZmhPVHZib1YwZUVsTm1ESw?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-07-17T07:00:00+00:00", "published_display": "17 Jul 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQX0RqMkl3NW9wM0hfc0UtZkY0VXhvTHR0SlpUR0xncXAwNmRPMGQ4UkpSLTh5dEFDMFo3c3lUb2E3UlI2NVdOTjR1U1NjOUplUmxoLTJ2SDUzWlRaN1hoSFhVYUF0b0VLMmtJSzV5endOcE9XM0I3WEJtMjlZN19Cc2FQX3lZS1o5R3VxbHJDRTZGbGctV0Nhd2JmZHNtbzVidUZ5VUhzMXduY1J1aE1uYlUzNWl2T1otU2c?oc=5", "source_name": "Reuters", "published_at": "2024-07-29T07:00:00+00:00", "published_display": "29 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxORk9ENlh5SlJsMWUxNEQxVlpSRENmeGxhU0hUdE02bERwWWZRSEZTeWRKZ1BuREhJOUppdTVnV0VjZ0tibGRpa0lzR1h4OXJNM1ZQdjA1YXVJbkZnd3N6U2xGX3hjaFVESWp5RWpQN2tOVG96ZnpCMUhZd0hha3NMZ3Z0Z1pEbHNpM2ZVSEFQQUVIQjFVTGNUUmlFNXhBQ3pmWWl3ODV5V29FeVdIVmNUMnJfN2xKTm9hQ3RGSTFqeEhIVGtrU3c?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-17T17:35:02+00:00", "published_display": "17 Jul 2026 17:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories Stock Draws Fresh Targets As Growth Story Builds", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE1SQXlNY2ZFUTA4bmlFdnY3dzF6ZHFmUzY3RkhwWERmVFVseTZoWEpyazZ4V1VoQ1ctdmp4QUFRZHN4bk5NM2tRRHB6OGhoYVRHVHpIRExkRWJKcnNabFRSZjhRUkwzaEZZZ2tFSVBWN2JIY0dienJyT3V5LWNQdw?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-16T20:03:00+00:00", "published_display": "16 Jul 2026 20:03", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Q2 Profit Plunges, Lifts FY26 Adj. EPS View, Backs Sales Forecast; Stock Up 11%", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQODRsZHJHSEhSU0lMQ1RxdU5adUt5YnRKS1JDb2d3UTBwQTFvbElDVHNtd2JHbjFzNVRkb19NNmtCX2ViSFBWOU9JWlQ0Y3I1cEM4ZW1NdDZoUGI4ZDcwY1JPc1hBRC1yRzdzak1yUDVBanZaMTJmUklFY2Z4VjRCZHBRS0dUbEhvNEgyejZTbHQ5SzhSQ1lJdUxnUFBwZVppT0NUZHl1Ykx3WGJ5bWVGMG9pLTMyczUzQVE?oc=5", "source_name": "RTTNews", "published_at": "2026-07-16T13:41:00+00:00", "published_display": "16 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector\u2019s 9% Earnings Drop", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnFlY0xtUFY4QVFXSFEzQVRZTVRtaVdRaXFUTlJuRk5TX1BhWTlVVU9sU3psYzQwU2haeTN5OFlNTlFzeHZmN05SRlZHNUVfTzc5VjJuRERSMURsU21Qb1NPai1kWU9TVElIb3B0WGZBQnBSSGdVbDR3YWhVcGZnUUs1NC1KMEpKWG5WU3c2bzlvQ19uLTF0ZjF4cGw2cG8?oc=5", "source_name": "TechStock\u00b2", "published_at": "2026-07-12T21:01:30+00:00", "published_display": "12 Jul 2026 21:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPcndKYnEwLTdDRXVCaUp2V0poRDlTdDRwd2JDdDlaWVY2T2FkVUxDamRlTzZQemdUaGVkTzc2Mk1ULVktTmVFRG9jd21iaWhFNFpaS3JqNVQwYUNuUUxtY1lmbmxSVmh2M2Q2Y3NPMk1RcFk1OTJNeldreTJ5NUxhc1FGSmF2NVpsTndjS0psdjR6d1VLWEJOeF9JRjE?oc=5", "source_name": "Market source", "published_at": "2026-07-08T07:00:00+00:00", "published_display": "08 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories (ABT) director granted 416 stock equivalent units as board fees", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPNi1pV2VVcGZkcVdqdDJJcGhOTUFUYm0zZVE2Z0piRDVlR1hMd1BNUnR3TVpoQlp1cm8tbUxlT2l5ckh1Y1E1UmRfeGRRYkdHWmluRmNPVksyZVV1WUN4VWQwMUkxa2FfMHJLN0ZBdmRQOGNHYWJDQjcwTU5PN3ZubXBuNU5DdE05eV9UeTBiYmlPMlkzQlZtV1hDZXlPSUZIZWRtdDhLM05yV2h1UVFFa21n?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott to post Q2 results July 16, then host live webcast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOQjFSSW9MR016TEhCLVlWZVVQVzFXYnhhN1NPTUJyc0FHWHdTVTV1UGZnTG10NHJ2d1JRNENMMzJZQ3A3OElsaUN5YUxMVXBPVzlCVnhVNEhYZy1HYjhWVDVXcVdDbVZTdU1acFdtNHVlY0dybVYtX0R3dUQ1Yk5fZHBfb3pQTUlqZmpIdVNJUzdrdks3OEhrT0tKa2k1YjV6Q2ZZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories confirms CE mark for dual sensor, shares in S&P 500 healthcare focus", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONDYxcWR1WG43R2dUVFN0NTRPRVJhSVZuXzFJdjBZMlBZa1A5UFFFak04N09uUTFsYUJvUzRNYWVpVVdGX0ROcVM2Zk1XQTdzZzdaMUo0X19NUHd6emtfak82NTlKbTA1OUtuZWNYTVEwc25FT25VR0RSWEVpRG5Tb0VaekFxWWEwQS1PSmRRcDRoaGhjVzNCdWZWU1FWM19ieW5Vc3BRcU1tUnh5VUlLMkEzWjNXRkprRHVIVXptR1BwcjRUa0k4Ug?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late to Buy Abbott Laboratories (ABT) After 4.4% Rally? GF Value Says Undervalued", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxQdUhoWU9jRktHbE9QWXliMWh2N2h0U2k1aTRobU5OalZZdmZQYVZ6RlZUZ182Q09XeGtIc1hCaGduTzJfX19Va0RaR2NJM1d1TFhLMzc4N3lONXVYT3pkeEFMOXk2dHJZUVBMbGExM016YlNEYWdobEE4dWYzc3JnMUUya0h5aGZrOFRUbnBEbWZOcXRxSWU5a0JEWXhHcFhQNWFQREdDLVhyTE54TGlmQXR5cmliYlVQTzBHWWNWTU5NOFlnNklkdE5FWWw3X0EySTlXMkEyb3JMRUZLenlxV2drVnpCZUhK?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock (US0028241000): U.S. healthcare name steadies after recent slide as instit", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxNM2J6VW9hcnU4OWloX1pIeGNTT0N5NGRTWUI4RkdCeFF2aWpmSExQRkhkbEladkFVbk9va0V5YXFnTW5lWXJUTkR0T1hLbFJFS2xwdHVjUzItOFpjODZXYkFfWFdSdk9ma3Mydmc1RzJnWm40Q2dHdlY2eWRkVHNwdzB4NGZFWXl3T0ExV0FpV3UyWGdnS0pLekVrVkxKZFdRaDZ0T1Z3Q2JnbHFmNzBiQjhCaDhEREtMdHdqQ0N3Ul81MjZK?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories stock (US0028241000): U.S. healthcare name steadies after recent ETF inclusion a", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQZWhUU0N2UFRxbG5kMlF3ZXBoMjhoczVwUmFzUXFGeldxNy15TXpaN2daTFRzNWdHR2pJUmJaYklMUlFZZTR5WlZJcklzT0ZycUtDb0g1c0MyS014NUtLY25JN180d2g4SHplY0dvUW9ZcUpscEVMYU0yNzZCZHFtRllMOS15Q2lEZXE1N1plcEFzZUc4RGtYS2JqYlFsclE0R2o1djlrSHZNc0VZTlE1c2gzRmdKcEVtMWs3LVZwb2xVMWkt?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-05-31T07:00:00+00:00", "published_display": "31 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026 - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMilgFBVV95cUxNdmo4V3NlWG1xTVBPZk1MWnBVOXRSempmSzVCSU5fV2FKTjJSYURsXzV3QjREZmJNSXNxc3NlbDl5d0V3eE5iWXRrWkh5YWI4UFZuQWs1Y3BCS09oNjZRZ0hlX29CT3FweGJPLWFkTndKUF85N05aaEYxVm5IclJGQTlTVVBzaG80Q0lWLVJEUkhuVElkQlE?oc=5", "source_name": "IndexBox", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ABT: Abbott Laboratories Director Acquires 10,000 Shares Amid De", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxOX0hYNm1YZHVEbklrQmt0RXV2akYzVkxXd3FhQU8wNkt4Z1V6V0ZvOGh1Vnl4UVBuRy1ITW1oWEtxWG5NUGhkM0xDQ0JPbloxblBPYXA3TlhwbklUdDdoX2RXUzFfQVl3VXdWXzBqQWI1RnNXNjl0YzREWUpqdXhIYnVsdG5xSTlYUkFsUGx0TGlaMks0azNCNVhINmNjM0RMSFp1M2J6bmVqZlpEMlYyUlpPRE1aRDY5LXhtTA?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-02T07:00:00+00:00", "published_display": "02 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon\u2122 3.0 Software", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNM3g4Mi1ySE9SOTk1bEJFYUd3cndHUkhIRllVMXVQb2czaFJuVVl0TDNoM0xMV0NfaFhMMDJaWUVMaF9aSHRyYUoxZHV3QUpXUWxuX3c3aGM1R1JfZ2xKNXZZdmtzejdlcmN3d0N1TkNFTlJRck5zQmpnX1ZkcmlUQ0JQRmdTREtBRk1mRjFveUdlRFV6SnhNcXNrVk9LcGM1V2hXLWMzV2I?oc=5", "source_name": "Market source", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (NYSE: ABT) CFO adds 2,200 shares in open-market buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOSUh2YlRhel83ZlF1cHdKZFhCMU1weHN4czY0TVdha2k3bnV4WXRyV190cEFYV3BocWJVTWJoOEJjWGpSRE54OFNxb0ptaW4xMjk4VzR0RW5kM0xjWlRaZ0VEbFVKVlRCSGhyXzBBLWxFaTlOX0RWa3hHWVFUV1pqLWx4YTN2NHVsanNJZGltMkVfS3JZek1oSkRqTHd3NDlZUC12dURodnNQSzd4Q1ZjYlFB?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOc2thQjFpazgwaFRfS3NjVXhlTkdFWHNFb240S0Z6akFtQXFIMmFmaXZnQ1A3OFVCQW9DT25OLVBQdGN5Yk52Mk9yUFlSX19ZS3FRTjZoR05zc2FVc25pVHQ0TDVHT2JmVnJabGNCREdLT2stV0IzLVdHWXpFZGU3V1NnVGhYbFRzNURVek41TVRmLWZQZTFYUkc4aXM0a1cwTkNFYTBfVnQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott (ABT) director Gonzalez receives 321 stock equivalent units as fees", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNX3lWTF81YXV2Z0F2dFlvaU0wZ2gwUjVyWURBVG5kLVZKODFnZDNES3FQYkRvdzBYTTFObmNtZ2VWY29BYUZPaWFZal9QcFA2d3doU1p4ejdkY2RHT0s0S0swUm9fVVpxNkRLMHNPd1M1XzV1OGtSYnI2SkJlY2NEakJxM0V4VjdxNXBXM0c0QXBZRVBhU3BUN2h5YkV6eGlSemhXcnZ4cWltdE16Y2VhWlV3?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxQR3R4V19DdlJINXJqRy1WQjhKTm4tck5oT1FOc1pYbjNCQUdXY1RLQmtoa21JQzVmRU95eUJQZDJjZjJudURxQlEyd2FkT0Zhckc3M2FLVjd6OU1ZSy02cE1nT25wNzdTRF9uNE43SmFuRGtNWHJ4SEhQalVCTXRBek55UkVGTWtYQW02bXVuenRxY0NaY0g2bXdrbGdHZEZaMTJKazBRMFkzb3pp?oc=5", "source_name": "IndexBox", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intuitive Surgical Upgraded to Buy by Citi \u2014 Plus Key Moves on Stryker and Abbott", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNNzUydURTRW1xNVVvR0JhTFl3NGZ5clhCY2IzWmtYZHd0R1d5WndyY3AwMGo5VGNucVdPbUt0U0tldW9Db1FiUGlqWkFwNU92T1dOVDhaV1VzTHNjalFVT1J2eWg5YmtKSHhxdk1SNDJwSkhGUU9LQUp5cXRFZ1d6Z0RBM2E4UjhJc2NoSkozNmQ1ZjZibFhYa0Zac0pkcFBPbzdGYlo4aHVTaU5OR0M2Sm00cmFaMmYyVzB6QW9uVEM?oc=5", "source_name": "24/7 Wall St.", "published_at": "2026-03-11T07:00:00+00:00", "published_display": "11 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After a 15% Drop, Is Abbott Stock Set Up for a Comeback in 2026?", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAFBVV95cUxNMDYzNGNjZlhLai1jcjJTcjBJOG5PNzNSdkhaLWRsd2dldFh6bHJUbUhiWGFteFhJSkVkNHBPUk16anJLVGROX0w3RGxrLUtHVERHd3JaWURBQ2xmSzFJWk80TWtkQnBPaElBSENubFlJQXN1cmlXVkI0UFowWm9Bb2Q3cFdkaHNBSDQ2MWtHLXk?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-10T08:00:00+00:00", "published_display": "10 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott Stock (ABT) Drops on Lower Full-Year Outlook; Sales Meet Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxONXhiOEFhUHFiQVhxRTFabXZYX3Jmc1BuZDhZczRMQmxZOE1NVzI5b2xZcW9qdnJzX2xpOEhfTjloMk91X1ptNVpSQWk2VGh2ZzhjVHhYVExGYXRZWVV6VjZRUjVBZ0x4ckNJd3F5RUdXS0dRcGtBdlp6WUI4bXB6UWVYc0NOYXZsVWhaWlpINEFPWDcxRWptQ2Z1Sl9MYzlyZmhPVHZib1YwZUVsTm1ESw?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-07-17T07:00:00+00:00", "published_display": "17 Jul 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxQX0RqMkl3NW9wM0hfc0UtZkY0VXhvTHR0SlpUR0xncXAwNmRPMGQ4UkpSLTh5dEFDMFo3c3lUb2E3UlI2NVdOTjR1U1NjOUplUmxoLTJ2SDUzWlRaN1hoSFhVYUF0b0VLMmtJSzV5endOcE9XM0I3WEJtMjlZN19Cc2FQX3lZS1o5R3VxbHJDRTZGbGctV0Nhd2JmZHNtbzVidUZ5VUhzMXduY1J1aE1uYlUzNWl2T1otU2c?oc=5", "source_name": "Reuters", "published_at": "2024-07-29T07:00:00+00:00", "published_display": "29 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 89, "total_relevant": 23, "sentiment_summary": {"positive": 5, "negative": 1, "neutral": 17, "score": 54, "total": 23, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 7.5, "count": 13}, {"event": "earnings", "label": "Earnings", "weight": 3.65, "count": 6}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.9, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 5, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 82.12, "latest_week": "2026-07-10", "one_week_move": -1.5, "four_week_move": 7.7, "twelve_week_move": 0.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.408665, "market_dynamics_buy_signal": true, "relative_strength": -18.305564, "fair_value_gap": -17.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 52.0346, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.5% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": ["Market Dynamics buy signal"], "opportunities": ["Market Dynamics is showing a buy signal in the latest weekly context."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "ad-hoc-news.de", "count": 4}, {"label": "Stock Titan", "count": 4}, {"label": "Market source", "count": 3}, {"label": "GuruFocus", "count": 2}, {"label": "IndexBox", "count": 2}, {"label": "StocksToTrade", "count": 1}, {"label": "RTTNews", "count": 1}, {"label": "TechStock\u00b2", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 23}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Earnings", "count": 6}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "23", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-1.5% over one week, +7.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Abbott Laboratories stock trades steadily as diagnostics and medical devices support earnings"}], "updated_at": "2026-07-17T22:37:16.759264+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}